Influence of Sugammadex on Facial Nerve Monitoring in Parotid Surgery
Phase of Trial: Phase IV
Latest Information Update: 29 Jan 2016
At a glance
- Drugs Sugammadex (Primary)
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 26 Dec 2015 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 31 Aug 2015 Planned End Date changed from 1 Jun 2015 to 1 Jul 2016, as reported by ClinicalTrials.gov.
- 31 Aug 2015 Planned primary completion date changed from 1 Jun 2015 to 1 Jul 2016, as reported by ClinicalTrials.gov.